Latest Content

Tracy Peck, RN, of Urology Specialists of the Carolinas, doubled her clinic's patient volume while creating "Elevator Bob," a peer support initiative that's now reached communities nationwide.

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from chemotherapy.

Amanda Smith, registered nurse, of Huntsman Cancer Institute, helped lead novel research on MPN drug safety during pregnancy, earning co-authorship and her mentor's highest praise.

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

A cancer survivor reflects on the receptionists, medical assistants and nurses whose kindness made treatment more manageable and less frightening.

Aurora Relampagos blends clinical expertise with compassion, leading scheduling innovations that cut wait times while mentoring colleagues and staff.

He thought CAR-T therapy marked the end of cancer. Months later, another diagnosis revealed the power of faith, hope and resilience.

Diagnosed with Hodgkin lymphoma at 18, Steve Garraty shares how survivorship, gratitude and purpose emerged from life's hardest chapter.

14 years after a rare lymphoma diagnosis, Edward Miskie answers real questions on survivorship, caregiving and life after cancer treatment.

FDA approves Trodelvy alone or with Keytruda for the first-line treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer.

Susan Yaguda, oncology nurse at Atrium Health Levine Cancer Institute, transforms cancer care by treating the whole person — mind, body, and spirit — one patient at a time.

FDA approves Ibrance with trastuzumab and endocrine therapy for maintenance treatment of HR-positive, HER2-positive metastatic breast cancer.

A four-time cancer survivor shares how the Mariana Trench mirrors the journey through cancer, resilience, hope, and survival.